Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-year intravenous zoledronate 4 mg for post-menopausal osteoporosis (open-label extension)
TCTR20250503008Phase 2Completed
- Sponsor
- N/A
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of zoledronate in osteoporosis, sponsored by N/A. Started Jul 2019; status: completed.
02
Drugs
zoledronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20250503008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250503008.